Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 12/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.34 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.33 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.33 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.33 |
| ▸ | ITGAL | P20701 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30901611 | 1.00 | AHR (1.00) | AHRALOX5MAOAMAOBNTSR1 | |
| SCHEMBL29617290 | 1.00 | AHR (1.00) | AHRALOX5MAOAMAOBNTSR1 | |
| SCHEMBL1078819 | 0.91 | AHR (0.82) | AHRALOX5MAOAMAOBNTSR1 | |
| Pentachlorophenol SCHEMBL6761630 | 0.89 | AHR (0.78) | AHRMAOAMAOBLMNATSHR | |
| SCHEMBL5588066 | 0.82 | AHR (0.70) | AHRALOX5MAOAMAOBNTSR1 | |
| SCHEMBL5885513 | 0.79 | AHR (1.00) | AHRTSHR | |
| SCHEMBL3172291 | 0.79 | AHR (0.69) | AHRLMNATSHR | |
| SCHEMBL29488626 | 0.79 | AHR (0.69) | AHRLMNATSHR | |
| SCHEMBL2886579 | 0.77 | AHR (0.73) | AHR | |
| SCHEMBL2463391 | 0.75 | AHR (0.59) | AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 549 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250367321-A1 | COMPOSITIONS AND METHODS INVOLVING ADGRG6 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-04 | — | — | US | claimed |
| WO-2023250130-A2 | COMPOSITIONS AND METHODS INVOLVING ADGRG6 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-12-28 | — | — | WO | claimed |
| CN-115406990-B | Method for detecting dioxin in chlorinated paraffin industrial products | RESEARCH CENTER FOR ECO-ENVIRONMENTAL SCIENCES, CHINESE ACADEMY OF SCIENCES (CN) | 2023-09-26 | — | — | CN | claimed |
| CN-115406990-A | Method for detecting dioxin in chlorinated paraffin industrial product | 中国科学院生态环境研究中心 | 2022-11-29 | — | — | CN | claimed |
| CN-115337911-A | Preparation method of dioxin molecularly imprinted material | 中山火炬职业技术学院 | 2022-11-15 | — | — | CN | claimed |
| CN-114444973-A | Food safety risk assessment program based on exposure characteristics, toxicity pathways and biomarkers and framework system construction method | 复旦大学 | 2022-05-06 | — | — | CN | claimed |
| US-20210299094-A1 | METHODS OF UPREGULATING TIPARP AS ANTICANCER STRATEGIES | CORNELL UNIVERSITY | 2021-09-30 | — | — | US | claimed |
| WO-2020023616-A1 | METHODS OF UPREGULATING TIPARP AS ANTICANCER STRATEGIES | CORNELL UNIVERSITY (US) | 2020-01-30 | — | — | WO | claimed |
| US-20180125971-A1 | Modulation of the Immune Response | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2018-05-10 | — | — | US | claimed |
| US-20180071376-A1 | TOLEROGENIC NANOPARTICLES FOR TREATING DIABETES MELLITUS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2018-03-15 | — | — | US | claimed |
| EP-0561786-A1 | BLEACHING CHEMICAL PULP USING CHLORINE/CHLORINE DIOXIDE THEN OZONE | INTERNATIONAL PAPER COMPANY (US) | 1993-09-29 | — | — | EP | claimed |
| WO-1992003609-A1 | BLEACHING CHEMICAL PULP USING CHLORINE/CHLORINE DIOXIDE THEN OZONE | INTERNATIONAL PAPER COMPANY (US) | 1992-03-05 | — | — | WO | claimed |
| EP-0252521-B1 | PROCESS FOR DECOMPOSING POLYHALOGENATED COMPOUNDS | Hagenmaier, Hanspaul, Prof.Dr. (DE) | 1991-10-09 | — | — | EP | claimed |
| US-4981650-A | Method for treatment of dioxin-contaminated media | NATIONAL SCIENCE FOUNDATION | 1991-01-01 | — | — | US | claimed |
| EP-0258006-A2 | Monoclonal antibodies reactive with chlorinated dibenzo-p-dioxins and method of preparing and using same | WESTINGHOUSE ELECTRIC CORPORATION (US) | 1988-03-02 | — | — | EP | claimed |
| WO-1988000483-A1 | PROCESS FOR DECOMPOSING POLYHALOGENATED COMPOUNDS | HAGENMAIER HANS PAUL (DE) | 1988-01-28 | — | — | WO | claimed |
| EP-0252521-A1 | Process for decomposing polyhalogenated compounds | Hagenmaier, Hanspaul, Prof.Dr. (DE) | 1988-01-13 | — | — | EP | claimed |
| EP-0251635-A2 | Monoclonal antibodies and method for detecting dioxins and dibenzofurans | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1988-01-07 | — | — | EP | claimed |
| EP-0021294-B1 | CHEMICAL DETOXIFICATION OF TOXIC CHLORINATED AROMATIC COMPOUNDS | Vertac Chemical Corporation (US) | 1984-10-10 | — | — | EP | claimed |
| EP-0027745-B1 | A PROCESS FOR THE ELECTROCHEMICAL DEGRADATION OF PERSISTENT ORGANIC COMPOUNDS, WITH HARMFUL OR POTENTIALLY HARMFUL PROPERTIES | CRECONSULT LIMITED (GB) | 1984-08-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210299094-A1 | METHODS OF UPREGULATING TIPARP AS ANTICANCER STRATEGIES | TIPARP, TEAD1, TEAD2 | AHR 143/4885ALOX5 3621/4885MAOA 1725/4885 |
| US-20180071376-A1 | TOLEROGENIC NANOPARTICLES FOR TREATING DIABETES MELLITUS | IAPP, NFATC1, CD4 | AHR 2191/4885ALOX5 3504/4885MAOA 4790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.